Regeneron Announces Investor Conference Presentations
- Credit Suisse 29th Annual
Virtual Healthcare Conferenceat 8:45 a.m. ESTon Monday, November 9, 2020
- Cowen Virtual Presentation Series – 2020 IO Next Summit at
1:15 p.m. ESTon Friday, November 13, 2020 Jefferies Virtual London Healthcare Conferenceat 7:20 a.m. EST( 12:20 p.m. GMT) on Tuesday, November 17, 2020
The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website for at least 30 days.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.